SARA R SCHOENFELD M.D.
Prescription History 1982925129
Internal Medicine - Rheumatology in Boston, MA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for SARA R SCHOENFELD M.D., an active Rheumatology specialist practicing in Boston, MA. Our medical registry currently tracks 24 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 960 documented patient claims. Among these therapy options, the most frequently utilized medication is Hydroxychloroquine Sulfate, which accounts for 168 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other MA PrescribersVs. MA Avg |
|---|---|---|---|
| Hydroxychloroquine Sulfate | 168 | $59.54▼ below MA avg | ▲ More than typical |
About Hydroxychloroquine Sulfate: Hydroxychloroquine is used to prevent or treat malaria caused by mosquito bites. Show more ▾ The United States Center for Disease Control provides updated guidelines and travel recommendations for the prevention and treatment of malaria in different parts of the world. Discuss the most recent information with your doctor before traveling to areas where malaria occurs. This medication is also used to treat certain auto-immune diseases (lupus, rheumatoid arthritis). It belongs to a class of medications known as disease-modifying antirheumatic drugs (DMARDs). It can reduce skin problems in lupus and prevent swelling/pain in arthritis. Hydroxychloroquine is not recommended for coronavirus infection, also known as COVID-19, unless you are enrolled in a study. Talk to your doctor about the risks and benefits. A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970) In 2023, this provider wrote 168 Medicare prescriptions for Hydroxychloroquine Sulfate, about 2.2 times the volume of the typical Massachusetts prescriber of this medication (78). Medicare paid an average of $59.54 per fill, versus $71.93 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 362.4 30-Day Fills standardized to 30-day supplies 10,847 Days of Medication total across all patients in 2023 | |||
| Prednisone | 165 | $11.16 | ▲ More than typical |
About Prednisone: Prednisone is used to treat conditions such as arthritis, blood disorders, breathing problems, severe allergies, skin diseases, cancer, eye problems, and immune system disorders. Show more ▾ Prednisone belongs to a class of drugs known as corticosteroids. It decreases your immune system's response to various diseases to reduce symptoms such as swelling and allergic-type reactions. A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. In 2023, this provider wrote 165 Medicare prescriptions for Prednisone, about 3.8 times the volume of the typical Massachusetts prescriber of this medication (44). Medicare paid an average of $11.16 per fill, versus $6.86 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 278 30-Day Fills standardized to 30-day supplies 7,886 Days of Medication total across all patients in 2023 | |||
| MethotrexateMethotrexate Sodium | 106 | $43.10▼ below MA avg | ≈ Typical |
About Methotrexate: Methotrexate is used to treat certain types of cancer (such as acute lymphoblastic leukemia, non-Hodgkin's lymphoma) or to control severe psoriasis or rheumatoid arthritis that has not responded to other treatments. Show more ▾ It may also be used to control juvenile rheumatoid arthritis. Methotrexate belongs to a class of drugs known as antimetabolites. It works by slowing or stopping the growth of cancer cells and suppressing the immune system. Early treatment of rheumatoid arthritis with more aggressive therapy such as methotrexate helps to reduce further joint damage and to preserve joint function. An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. In 2023, this provider wrote 106 Medicare prescriptions for Methotrexate, about 1.2 times the volume of the typical Massachusetts prescriber of this medication (86). Medicare paid an average of $43.10 per fill, versus $46.93 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 255.2 30-Day Fills standardized to 30-day supplies 7,565 Days of Medication total across all patients in 2023 | |||
| Humira(Cf) PenAdalimumab | 59 | $7,882.36▼ below MA avg | ▲ More than typical |
About Humira(Cf) Pen: Adalimumab is used to reduce pain and swelling due to certain types of arthritis (such as rheumatoid, psoriatic, juvenile idiopathic, ankylosing spondylitis). Show more ▾ This medication is also used to treat certain skin disorders (such as plaque-type psoriasis, hidradenitis suppurativa). It works by blocking a protein (tumor necrosis factor or TNF) found in the body's immune system that causes joint swelling and damage in arthritis as well as red scaly patches in psoriasis. Adalimumab belongs to a class of drugs known as TNF blockers. By reducing joint swelling, this medication helps to reduce further joint damage and preserve joint function. Adalimumab is also used to treat certain bowel conditions (Crohn's disease, ulcerative colitis) and a certain eye disease (uveitis). A humanized monoclonal antibody that binds specifically to TNF-ALPHA and blocks its interaction with endogenous TNF RECEPTORS to modulate INFLAMMATION. It is used in the treatment of RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS; CROHN'S DISEASE and ULCERATIVE COLITIS. In 2023, this provider wrote 59 Medicare prescriptions for Humira(Cf) Pen, about 1.7 times the volume of the typical Massachusetts prescriber of this medication (35). Medicare paid an average of $7,882.36 per fill, versus $8,419.95 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 62.5 30-Day Fills standardized to 30-day supplies 1,764 Days of Medication total across all patients in 2023 | |||
| Diclofenac Sodium | 54 | $33.79 | ▲ More than typical |
About Diclofenac Sodium: See also Warning section. Show more ▾ This medication is used to relieve joint pain from arthritis. Diclofenac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt. In 2023, this provider wrote 54 Medicare prescriptions for Diclofenac Sodium, about 1.4 times the volume of the typical Massachusetts prescriber of this medication (39). Medicare paid an average of $33.79 per fill, versus $29.69 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 58.5 30-Day Fills standardized to 30-day supplies 980 Days of Medication total across all patients in 2023 | |||
| Lidocaine | 42 | $137.75▼ below MA avg | ▲ More than typical |
About Lidocaine: This product is used to help reduce itching and pain from certain skin conditions (such as scrapes, minor skin irritations, insect bites). Show more ▾ It may also be used to help relieve nerve pain after shingles (infection with herpes zoster virus). Lidocaine belongs to a class of drugs known as local anesthetics. It works by causing a temporary loss of feeling in the area where you apply the patch. A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE. In 2023, this provider wrote 42 Medicare prescriptions for Lidocaine, about 1.7 times the volume of the typical Massachusetts prescriber of this medication (25). Medicare paid an average of $137.75 per fill, versus $165.22 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 50 30-Day Fills standardized to 30-day supplies 1,484 Days of Medication total across all patients in 2023 | |||
| Allopurinol | 40 | $20.63 | ≈ Typical |
About Allopurinol: Allopurinol is used to treat gout and certain types of kidney stones. Show more ▾ It is also used to prevent increased uric acid levels in patients receiving cancer chemotherapy. These patients can have increased uric acid levels due to release of uric acid from the dying cancer cells. Allopurinol works by reducing the amount of uric acid made by the body. Increased uric acid levels can cause gout and kidney problems. A XANTHINE OXIDASE inhibitor that decreases URIC ACID production. It also acts as an antimetabolite on some simpler organisms. In 2023, this provider wrote 40 Medicare prescriptions for Allopurinol, about the same volume as the typical Massachusetts prescriber of this medication (44). Medicare paid an average of $20.63 per fill, versus $16.91 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 116.5 30-Day Fills standardized to 30-day supplies 3,495 Days of Medication total across all patients in 2023 | |||
| Enbrel SureclickEtanercept | 31 | $8,437.80 | ≈ Typical |
About Enbrel Sureclick: This medication is used alone or in combination with an immunosuppressant (such as methotrexate) to treat certain types of arthritis (such as rheumatoid, psoriatic, juvenile idiopathic, and ankylosing spondylitis). Show more ▾ Some brands of this medication are also used to treat a skin condition called psoriasis. These conditions are caused by an overactive immune system (autoimmune disease). The immune system attacks the body's own healthy cells, causing inflammation in the joints and skin. Etanercept controls your body's defensive response by blocking the action of a certain natural substance (TNF) that is used by the immune system. Treatment decreases redness, itching and scaly patches in psoriasis as well as the pain, swelling and stiffness of joints in arthritis. This medication can stop the progression of disease and joint damage, resulting in improved daily functioning and quality of life. This medication treats but does not cure autoimmune diseases. Symptoms usually return within 1 month of stopping the medication. A recombinant version of soluble human TNF receptor fused to an IgG FC fragment that binds specifically to TUMOR NECROSIS FACTOR and inhibits its binding with endogenous TNF receptors. It prevents the inflammatory effect of TNF and is used to treat RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS and ANKYLOSING SPONDYLITIS. In 2023, this provider wrote 31 Medicare prescriptions for Enbrel Sureclick, about 76% of the volume of the typical Massachusetts prescriber of this medication (41). Medicare paid an average of $8,437.80 per fill, versus $7,098.38 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 34.6 30-Day Fills standardized to 30-day supplies 980 Days of Medication total across all patients in 2023 | |||
| Actemra ActpenTocilizumab | 25 | $4,484.08 | ≈ Typical |
About Actemra Actpen: This medication is used to treat rheumatoid arthritis in adults and in children (such as systemic juvenile idiopathic arthritis-SJIA, polyarticular juvenile idiopathic arthritis-PJIA). Show more ▾ It helps to reduce pain and swelling due to rheumatoid arthritis. Tocilizumab can also be used to treat giant cell arteritis. It helps to reduce swelling in your blood vessels so blood can flow more easily. Tocilizumab may also be used to treat a reaction (Cytokine Release Syndrome-CRS) caused by certain cancer treatments. Tocilizumab belongs to a class of drugs known as Interleukin-6 (IL-6) blockers. It works by blocking IL-6, a substance made by the body that causes swelling (inflammation). Tocilizumab is used in combination with a corticosteroid (such as dexamethasone) to treat coronavirus disease (COVID-19) in hospitalized patients who need supplemental oxygen (including patients on a mechanical ventilator). The FDA is allowing tocilizumab to be used to treat coronavirus disease in human studies and for emergency use. Tocilizumab is approved to be used in Canada to treat coronavirus disease. If tocilizumab is used to treat coronavirus disease, more information about the drug is available from the patient information sheet provided by your health care professional. If you are enrolled in a study, information should be provided by the doctor via the Informed Consent Form. In 2023, this provider wrote 25 Medicare prescriptions for Actemra Actpen, about the same volume as the typical Massachusetts prescriber of this medication (23). Medicare paid an average of $4,484.08 per fill, versus $3,868.89 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 25 30-Day Fills standardized to 30-day supplies 700 Days of Medication total across all patients in 2023 | |||
| ActemraTocilizumab | 23 | $2,866.06▼ below MA avg | ≈ Typical |
About Actemra: This medication is used to treat rheumatoid arthritis in adults and in children (such as systemic juvenile idiopathic arthritis-SJIA, polyarticular juvenile idiopathic arthritis-PJIA). Show more ▾ It helps to reduce pain and swelling due to rheumatoid arthritis. Tocilizumab can also be used to treat giant cell arteritis. It helps to reduce swelling in your blood vessels so blood can flow more easily. Tocilizumab may also be used to treat a reaction (Cytokine Release Syndrome-CRS) caused by certain cancer treatments. Tocilizumab belongs to a class of drugs known as Interleukin-6 (IL-6) blockers. It works by blocking IL-6, a substance made by the body that causes swelling (inflammation). Tocilizumab is used in combination with a corticosteroid (such as dexamethasone) to treat coronavirus disease (COVID-19) in hospitalized patients who need supplemental oxygen (including patients on a mechanical ventilator). The FDA is allowing tocilizumab to be used to treat coronavirus disease in human studies and for emergency use. Tocilizumab is approved to be used in Canada to treat coronavirus disease. If tocilizumab is used to treat coronavirus disease, more information about the drug is available from the patient information sheet provided by your health care professional. If you are enrolled in a study, information should be provided by the doctor via the Informed Consent Form. In 2023, this provider wrote 23 Medicare prescriptions for Actemra, about the same volume as the typical Massachusetts prescriber of this medication (21). Medicare paid an average of $2,866.06 per fill, versus $4,053.48 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 23 30-Day Fills standardized to 30-day supplies 644 Days of Medication total across all patients in 2023 | |||
| Sulfasalazine | 23 | $17.81▼ below MA avg | ≈ Typical |
About Sulfasalazine: Sulfasalazine is used to treat a certain type of bowel disease called ulcerative colitis. Show more ▾ This medication does not cure this condition, but it helps decrease symptoms such as fever, stomach pain, diarrhea, and rectal bleeding. After an attack is treated, sulfasalazine is also used to increase the amount of time between attacks. This medication works by reducing irritation and swelling in the large intestines. In addition, delayed-release tablets of sulfasalazine are used to treat rheumatoid arthritis. Sulfasalazine helps to reduce joint pain, swelling, and stiffness. Early treatment of rheumatoid arthritis with sulfasalazine helps to reduce/prevent further joint damage so you can do more of your normal daily activities. This medication is used with other drugs, rest, and physical therapy in patients who have not responded to other medications (salicylates, nonsteroidal anti-inflammatory drugs-NSAIDs). A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907) In 2023, this provider wrote 23 Medicare prescriptions for Sulfasalazine, about 79% of the volume of the typical Massachusetts prescriber of this medication (29). Medicare paid an average of $17.81 per fill, versus $32.55 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 40 30-Day Fills standardized to 30-day supplies 1,187 Days of Medication total across all patients in 2023 | |||
| Cosentyx Sensoready (2 Pens)Secukinumab | 21 | $7,395.71 | – No State Data |
About Cosentyx Sensoready (2 Pens): This medication is used to treat plaque psoriasis and certain types of arthritis (such as arthritis of the spine, psoriatic arthritis, axial spondyloarthritis, enthesitis-related arthritis). Show more ▾ Secukinumab belongs to a class of drugs known as monoclonal antibodies. It works by blocking a certain natural protein in your body (interleukin-17A) that may cause inflammation and swelling. In 2023, this provider wrote 21 Medicare prescriptions for Cosentyx Sensoready (2 Pens). Medicare paid an average of $7,395.71 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $7,395.71 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 21 30-Day Fills standardized to 30-day supplies 588 Days of Medication total across all patients in 2023 | |||
| Folic Acid | 20 | $3.78▼ below MA avg | ≈ Typical |
About Folic Acid: Folic acid is the man-made form of folate. Show more ▾ Folate is a B-vitamin naturally found in some foods. It is needed to form healthy cells, especially red blood cells. Folic acid supplements may come in different forms (such as L-methylfolate, levomefolate, methyltetrahydrofolate). They are used to treat or prevent low folate levels. Low folate levels can lead to certain types of anemia. Conditions that can cause low folate levels include poor diet, pregnancy, alcoholism, liver disease, certain stomach/intestinal problems, kidney dialysis, among others. Women of childbearing age should receive adequate amounts of folic acid either through their diet or supplements to prevent infant spinal cord birth defects. A member of the vitamin B family that stimulates the hematopoietic system. It is present in the liver and kidney and is found in mushrooms, spinach, yeast, green leaves, and grasses (POACEAE). Folic acid is used in the treatment and prevention of folate deficiencies and megaloblastic anemia. In 2023, this provider wrote 20 Medicare prescriptions for Folic Acid, about the same volume as the typical Massachusetts prescriber of this medication (21). Medicare paid an average of $3.78 per fill, versus $5.36 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 56 30-Day Fills standardized to 30-day supplies 1,680 Days of Medication total across all patients in 2023 | |||
| Mycophenolate Mofetil | 20 | $246.11 | ▼ Less than typical |
About Mycophenolate Mofetil: Mycophenolate is used in combination with other medications to keep your body from attacking and rejecting your transplanted organ (such as kidney, liver, heart). Show more ▾ It belongs to a class of medications called immunosuppressants. It works by weakening your body's defense system (immune system) to help your body accept the new organ as if it were your own. Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase (IMP DEHYDROGENASE). Mycophenolic acid exerts selective effects on the immune system in which it prevents the proliferation of T-CELLS, LYMPHOCYTES, and the formation of antibodies from B-CELLS. It may also inhibit recruitment of LEUKOCYTES to sites of INFLAMMATION. In 2023, this provider wrote 20 Medicare prescriptions for Mycophenolate Mofetil, about 71% of the volume of the typical Massachusetts prescriber of this medication (28). Medicare paid an average of $246.11 per fill, versus $182.40 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 35 30-Day Fills standardized to 30-day supplies 1,028 Days of Medication total across all patients in 2023 | |||
| Colchicine | 19 | $40.59▼ below MA avg | ≈ Typical |
About Colchicine: This medication is used to prevent or treat gout attacks (flares). Show more ▾ Usually gout symptoms develop suddenly and involve only one or a few joints. The big toe, knee, or ankle joints are most often affected. Gout is caused by too much uric acid in the blood. When uric acid levels in the blood are too high, the uric acid may form hard crystals in your joints. Colchicine works by decreasing swelling and lessening the build up of uric acid crystals that cause pain in the affected joint(s). This medication is also used to prevent attacks of pain in the abdomen, chest, or joints caused by a certain inherited disease (familial Mediterranean fever). It is thought to work by decreasing your body's production of a certain protein (amyloid A) that builds up in people with familial Mediterranean fever. Colchicine is not a pain medication and should not be used to relieve other causes of pain. A major alkaloid from Colchicum autumnale L. and found also in other Colchicum species. Its primary therapeutic use is in the treatment of gout, but it has been used also in the therapy of familial Mediterranean fever (PERIODIC DISEASE). In 2023, this provider wrote 19 Medicare prescriptions for Colchicine, about the same volume as the typical Massachusetts prescriber of this medication (21). Medicare paid an average of $40.59 per fill, versus $131.71 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 47.5 30-Day Fills standardized to 30-day supplies 1,425 Days of Medication total across all patients in 2023 | |||
| RinvoqUpadacitinib | 19 | $6,599.86 | ▼ Less than typical |
About Rinvoq: Upadacitinib is used to treat certain types of arthritis (such as psoriatic arthritis, rheumatoid arthritis, axial spondyloarthritis). Show more ▾ It helps decrease pain, tenderness, and swelling in the joints. Upadacitinib is also used to treat a skin condition called atopic dermatitis. It reduces swelling, itching, and redness in the skin. This medication may also be used to treat a certain bowel disease (ulcerative colitis). It helps to reduce symptoms of ulcerative colitis such as diarrhea, rectal bleeding, and stomach pain. In 2023, this provider wrote 19 Medicare prescriptions for Rinvoq, about 73% of the volume of the typical Massachusetts prescriber of this medication (26). Medicare paid an average of $6,599.86 per fill, versus $6,078.58 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 20 30-Day Fills standardized to 30-day supplies 600 Days of Medication total across all patients in 2023 | |||
| Gabapentin | 18 | $26.03 | ▼ Less than typical |
About Gabapentin: Gabapentin is used with other medications to prevent and control seizures. Show more ▾ It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug. A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME. In 2023, this provider wrote 18 Medicare prescriptions for Gabapentin, about a quarter of the volume of the typical Massachusetts prescriber of this medication (79). Medicare paid an average of $26.03 per fill, versus $20.16 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 44 30-Day Fills standardized to 30-day supplies 1,320 Days of Medication total across all patients in 2023 | |||
| Leflunomide | 17 | $173.06 | ▼ Less than typical |
About Leflunomide: This medication is used to treat rheumatoid arthritis, a condition in which the body's defense system (immune system) fails to recognize the body as itself and attacks the healthy tissues around the joints. Show more ▾ Leflunomide helps to reduce the joint damage/pain/swelling and helps you to move better. It works by weakening your immune system and decreasing swelling (inflammation). An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS. In 2023, this provider wrote 17 Medicare prescriptions for Leflunomide, about a third of the volume of the typical Massachusetts prescriber of this medication (51). Medicare paid an average of $173.06 per fill, versus $115.58 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 23 30-Day Fills standardized to 30-day supplies 654 Days of Medication total across all patients in 2023 | |||
| Methotrexate SodiumMethotrexate Sodium/Pf | 16 | $22.34 | ▼ Less than typical |
About Methotrexate Sodium: Methotrexate is used to treat certain types of cancer (such as acute lymphoblastic leukemia, non-Hodgkin's lymphoma) or to control severe psoriasis or rheumatoid arthritis that has not responded to other treatments. Show more ▾ It may also be used to control juvenile rheumatoid arthritis. Methotrexate belongs to a class of drugs known as antimetabolites. It works by slowing or stopping the growth of cancer cells and suppressing the immune system. Early treatment of rheumatoid arthritis with more aggressive therapy such as methotrexate helps to reduce further joint damage and to preserve joint function. An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. In 2023, this provider wrote 16 Medicare prescriptions for Methotrexate Sodium, about 64% of the volume of the typical Massachusetts prescriber of this medication (25). Medicare paid an average of $22.34 per fill, versus $16.92 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 37.2 30-Day Fills standardized to 30-day supplies 1,091 Days of Medication total across all patients in 2023 | |||
| Methylprednisolone | 16 | $11.02▼ below MA avg | ▼ Less than typical |
About Methylprednisolone: Methylprednisolone is used to treat conditions such as arthritis, blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/kidney/intestinal/lung diseases, and immune system disorders. Show more ▾ It decreases your immune system's response to various diseases to reduce symptoms such as swelling, pain, and allergic-type reactions. This medication is a corticosteroid hormone. Methylprednisolone may also be used with other medications in hormone disorders. A PREDNISOLONE derivative with similar anti-inflammatory action. In 2023, this provider wrote 16 Medicare prescriptions for Methylprednisolone, about half the volume of the typical Massachusetts prescriber of this medication (29). Medicare paid an average of $11.02 per fill, versus $14.07 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 17.9 30-Day Fills standardized to 30-day supplies 489 Days of Medication total across all patients in 2023 | |||
| Celecoxib | 16 | $55.80 | ▼ Less than typical |
About Celecoxib: This medication is a nonsteroidal anti-inflammatory drug (NSAID), specifically a COX-2 inhibitor, which relieves pain and swelling (inflammation). Show more ▾ It is used to treat arthritis, acute pain, and menstrual pain and discomfort. The pain and swelling relief provided by this medication helps you perform more of your normal daily activities. If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. See also Warning section. This drug works by blocking the enzyme in your body that makes prostaglandins. Decreasing prostaglandins helps to reduce pain and swelling. A pyrazole derivative and selective CYCLOOXYGENASE 2 INHIBITOR that is used to treat symptoms associated with RHEUMATOID ARTHRITIS; OSTEOARTHRITIS and JUVENILE ARTHRITIS, as well as the management of ACUTE PAIN. In 2023, this provider wrote 16 Medicare prescriptions for Celecoxib, about half the volume of the typical Massachusetts prescriber of this medication (32). Medicare paid an average of $55.80 per fill, versus $50.34 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 16 30-Day Fills standardized to 30-day supplies 480 Days of Medication total across all patients in 2023 | |||
| Leucovorin Calcium | 15 | $31.43▼ below MA avg | ▼ Less than typical |
About Leucovorin Calcium: This medication is used to treat or prevent serious blood cell disorders (such as thrombocytopenia, neutropenia, anemia) caused by certain drugs (folic acid antagonists such as methotrexate, trimethoprim, pyrimethamine). Show more ▾ It may also be used with a certain cancer drug (5-fluorouracil) to treat patients with colon cancer. Leucovorin may also be used to treat a certain type of anemia (due to folic acid deficiency) when folic acid cannot be taken by mouth. In 2023, this provider wrote 15 Medicare prescriptions for Leucovorin Calcium, about a third of the volume of the typical Massachusetts prescriber of this medication (38). Medicare paid an average of $31.43 per fill, versus $44.86 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 41.7 30-Day Fills standardized to 30-day supplies 1,251 Days of Medication total across all patients in 2023 | |||
| KevzaraSarilumab | 14 | $4,980.07 | ▼ Less than typical |
About Kevzara: This medication is used alone or with other medications to treat moderate to severe rheumatoid arthritis. Show more ▾ It helps to reduce pain and swelling due to rheumatoid arthritis. Sarilumab belongs to a class of drugs known as monoclonal antibodies. It works by blocking Interleukin-6, a substance made by the body that causes swelling (inflammation) in areas affected by rheumatoid arthritis. In 2023, this provider wrote 14 Medicare prescriptions for Kevzara, about 74% of the volume of the typical Massachusetts prescriber of this medication (19). Medicare paid an average of $4,980.07 per fill, versus $4,298.76 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 14 30-Day Fills standardized to 30-day supplies 392 Days of Medication total across all patients in 2023 | |||
| Sildenafil Citrate | 13 | $118.67▼ below MA avg | ▼ Less than typical |
About Sildenafil Citrate: Sildenafil is used to treat high blood pressure in the lungs (pulmonary hypertension). Show more ▾ It works by relaxing and widening the blood vessels in your lungs which allows the blood to flow more easily. Decreasing high blood pressure in the lungs allows your heart and lungs to work better and improves your ability to exercise. This medication is not recommended for use in children. Discuss the risks and benefits of this medication with the doctor. A PHOSPHODIESTERASE TYPE-5 INHIBITOR; VASODILATOR AGENT and UROLOGICAL AGENT that is used in the treatment of ERECTILE DYSFUNCTION and PRIMARY PULMONARY HYPERTENSION. In 2023, this provider wrote 13 Medicare prescriptions for Sildenafil Citrate, about 65% of the volume of the typical Massachusetts prescriber of this medication (20). Medicare paid an average of $118.67 per fill, versus $131.43 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 37.3 30-Day Fills standardized to 30-day supplies 1,120 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for SARA R SCHOENFELD M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Rheumatology prescribing approach at this Boston, MA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among MA prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
